Literature DB >> 22367358

Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy.

Susanne Philippi1, Anne Bigot, Andreas Marg, Vincent Mouly, Simone Spuler, Ute Zacharias.   

Abstract

Dysferlin gene mutations causing LGMD2B are associated with defects in muscle membrane repair. Four stable cell lines have been established from primary human dysferlin-deficient myoblasts harbouring different mutations in the dysferlin gene. We have compared immortalized human myoblasts and myotubes carrying disease-causing mutations in dysferlin to their wild-type counterparts. Fusion of myoblasts into myotubes and expression of muscle-specific differentiation markers were investigated with special emphasis on dysferlin protein expression, subcellular localization and function in membrane repair. We found that the immortalized myoblasts and myotubes were virtually indistinguishable from their parental cell line for all of the criteria we investigated. They therefore will provide a very useful tool to further investigate dysferlin function and pathophysiology as well as to test therapeutic strategies at the cellular level.

Entities:  

Year:  2012        PMID: 22367358      PMCID: PMC3274833.1          DOI: 10.1371/currents.RRN1298

Source DB:  PubMed          Journal:  PLoS Curr        ISSN: 2157-3999


  24 in total

1.  From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.

Authors:  Lars Klinge; Steve Laval; Sharon Keers; Faye Haldane; Volker Straub; Rita Barresi; Kate Bushby
Journal:  FASEB J       Date:  2007-03-15       Impact factor: 5.191

2.  Normal myoblast fusion requires myoferlin.

Authors:  Katherine R Doherty; Andrew Cave; Dawn Belt Davis; Anthony J Delmonte; Avery Posey; Judy U Earley; Michele Hadhazy; Elizabeth M McNally
Journal:  Development       Date:  2005-11-09       Impact factor: 6.868

3.  The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.

Authors:  C Matsuda; Y K Hayashi; M Ogawa; M Aoki; K Murayama; I Nishino; I Nonaka; K Arahata; R H Brown
Journal:  Hum Mol Genet       Date:  2001-08-15       Impact factor: 6.150

4.  Replicative aging down-regulates the myogenic regulatory factors in human myoblasts.

Authors:  Anne Bigot; Virginie Jacquemin; Florence Debacq-Chainiaux; Gillian S Butler-Browne; Olivier Toussaint; Denis Furling; Vincent Mouly
Journal:  Biol Cell       Date:  2008-03       Impact factor: 4.458

5.  Mechanisms of muscle weakness in muscular dystrophy.

Authors:  Jeffery A Goldstein; Elizabeth M McNally
Journal:  J Gen Physiol       Date:  2010-07       Impact factor: 4.086

6.  Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing.

Authors:  Niall J Lennon; Alvin Kho; Brian J Bacskai; Sarah L Perlmutter; Bradley T Hyman; Robert H Brown
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

7.  Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.

Authors:  Alexis R Demonbreun; John P Fahrenbach; Kieran Deveaux; Judy U Earley; Peter Pytel; Elizabeth M McNally
Journal:  Hum Mol Genet       Date:  2010-12-01       Impact factor: 6.150

8.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.

Authors:  J Liu; M Aoki; I Illa; C Wu; M Fardeau; C Angelini; C Serrano; J A Urtizberea; F Hentati; M B Hamida; S Bohlega; E J Culper; A A Amato; K Bossie; J Oeltjen; K Bejaoui; D McKenna-Yasek; B A Hosler; E Schurr; K Arahata; P J de Jong; R H Brown
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

9.  Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders.

Authors:  Kamel Mamchaoui; Capucine Trollet; Anne Bigot; Elisa Negroni; Soraya Chaouch; Annie Wolff; Prashanth K Kandalla; Solenne Marie; James Di Santo; Jean Lacau St Guily; Francesco Muntoni; Jihee Kim; Susanne Philippi; Simone Spuler; Nicolas Levy; Sergiu C Blumen; Thomas Voit; Woodring E Wright; Ahmed Aamiri; Gillian Butler-Browne; Vincent Mouly
Journal:  Skelet Muscle       Date:  2011-11-01       Impact factor: 4.912

10.  Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.

Authors:  Yen-Hui Chiu; Mark A Hornsey; Lars Klinge; Louise H Jørgensen; Steven H Laval; Richard Charlton; Rita Barresi; Volker Straub; Hanns Lochmüller; Kate Bushby
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

View more
  15 in total

1.  Cell Membrane Repair Assay Using a Two-photon Laser Microscope.

Authors:  Joshua J A Lee; Rika Maruyama; Hidetoshi Sakurai; Toshifumi Yokota
Journal:  J Vis Exp       Date:  2018-01-02       Impact factor: 1.355

2.  Altered expression of cyclin A 1 in muscle of patients with facioscapulohumeral muscle dystrophy (FSHD-1).

Authors:  Anna Pakula; Joanna Schneider; Jürgen Janke; Ute Zacharias; Herbert Schulz; Norbert Hübner; Anja Mähler; Andreas Spuler; Simone Spuler; Pierre Carlier; Michael Boschmann
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

3.  Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiation.

Authors:  Daniel Horbelt; Jan H Boergermann; Apirat Chaikuad; Ivan Alfano; Eleanor Williams; Ilya Lukonin; Tobias Timmel; Alex N Bullock; Petra Knaus
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

4.  Skeletal muscle characteristics are preserved in hTERT/cdk4 human myogenic cell lines.

Authors:  Matthew Thorley; Stéphanie Duguez; Emilia Maria Cristina Mazza; Sara Valsoni; Anne Bigot; Kamel Mamchaoui; Brennan Harmon; Thomas Voit; Vincent Mouly; William Duddy
Journal:  Skelet Muscle       Date:  2016-12-08       Impact factor: 4.912

5.  IRS4, a novel modulator of BMP/Smad and Akt signalling during early muscle differentiation.

Authors:  Gina Dörpholz; Arunima Murgai; Jerome Jatzlau; Daniel Horbelt; Mohammad Poorgholi Belverdi; Christina Heroven; Isabelle Schreiber; Gisela Wendel; Karen Ruschke; Sigmar Stricker; Petra Knaus
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

6.  Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy.

Authors:  Xue Dong; Xianjun Gao; Yi Dai; Ning Ran; HaiFang Yin
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

7.  Dysferlin-peptides reallocate mutated dysferlin thereby restoring function.

Authors:  Verena Schoewel; Andreas Marg; Severine Kunz; Tim Overkamp; Romy Siegert Carrazedo; Ute Zacharias; Peter T Daniel; Simone Spuler
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

8.  Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion.

Authors:  A Defour; J H Van der Meulen; R Bhat; A Bigot; R Bashir; K Nagaraju; J K Jaiswal
Journal:  Cell Death Dis       Date:  2014-06-26       Impact factor: 8.469

9.  The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes.

Authors:  Luis A Cea; Jorge A Bevilacqua; Christian Arriagada; Ana María Cárdenas; Anne Bigot; Vincent Mouly; Juan C Sáez; Pablo Caviedes
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

10.  Dysferlinopathy Fibroblasts Are Defective in Plasma Membrane Repair.

Authors:  Chie Matsuda; Kazuyuki Kiyosue; Ichizo Nishino; Yuichi Goto; Yukiko K Hayashi
Journal:  PLoS Curr       Date:  2015-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.